Vext Science Stock Price, News & Analysis

Vext Science (OTCQX:VEXTF) reported exceptional Q2 2025 financial results, with revenue reaching $13.4 million, up 59% year-over-year and a sequential increase of $1.8 million. The company achieved record Adjusted EBITDA of $4.1 million, a significant increase from Q2 2024, and operating cash flow of $4.2 million with a 31% Cash Flow Margin.

The strong performance was driven by Ohio momentum, where Vext strengthened its retail footprint to four consolidated locations, and disciplined operations in Arizona. The company is on track to reach Ohio's state dispensary license cap of eight by early 2026. Notable Q2 developments include completing the Big Perm dispensaries acquisition, selling a Kentucky processing license for $0.9 million, and opening a new dispensary in Portsmouth, Ohio.

Vext Science (OTCQX: VEXTF), a cannabis operator with operations in Arizona and Ohio, has scheduled its Q2 2025 financial results announcement for August 20, 2025, before market open.

The company will host a conference call and webcast on the same day at 8:00 AM ET. Investors can access the call via dial-in numbers or webcast, with a replay available until September 3, 2025.

Vext Science (OTCQX:VEXTF) has secured a provisional license for its sixth Ohio dispensary in Fairfield, marking continued expansion in the state. The 3,825 square foot facility, expected to be operational in Q4 2025, will be strategically located next to Jungle Jim's International Market, benefiting from high consumer traffic.

The company will invest approximately $1 million in the build-out, funded through operating cash flow. The location features a drive-thru format and holds exclusive rights as the only permitted dispensary in Fairfield. This expansion advances Vext's progress toward Ohio's dispensary license cap of eight locations, complementing its existing vertically integrated operations including a Tier 1 cultivation facility and manufacturing operations.

Vext Science (VEXTF) has opened its fifth cannabis dispensary in Portsmouth, Ohio, featuring a drive-thru service. The location, operating under provisional license from Ohio's Division of Cannabis Control, commenced operations on June 13, 2025. While awaiting final license transfer expected in Q3-Q4 2025, this expansion advances Vext toward Ohio's dispensary cap of eight locations. The company operates a vertically integrated platform in Ohio, including a 25,000 sq ft Tier 1 cultivation facility (expandable to 50,000 sq ft), a manufacturing facility, and five operational dispensaries serving both medical and adult-use consumers. Vext has received approval to develop three additional dual-use dispensaries under the DCC's 10(B) license program, with target locations pending announcement upon provisional permit issuance.

Vext Science, a U.S.-based cannabis operator with operations in Arizona and Ohio, announced a change in its auditor from Reliant CPA to MNP LLP effective June 4, 2025. The former auditor, Reliant CPA, resigned voluntarily, citing that Vext's growth and operational scale had exceeded their audit practice scope. The company's audit committee selected MNP LLP as the successor due to their greater public company experience and capacity to handle Vext's financial reporting requirements. There were no reservations, modified opinions, or reportable events in the former auditor's reports. The change of auditor notice and required documentation have been filed on SEDAR+.

Vext Science reported strong Q1 2025 financial results with revenue growing 38% to $11.6 million compared to Q1 2024, and up 13% sequentially from Q4 2024. The company achieved record operating cash flow of $3.1 million, matching its entire 2024 cash generation. The growth was primarily driven by expansion in Ohio, where Vext doubled its retail footprint to four locations through acquisitions in Athens and Jeffersonville. The company's Adjusted EBITDA reached $3.4 million with a 29% margin. Vext's retail-first strategy and capital-light build-out model in Ohio is proving successful, with new stores becoming profitable almost immediately. The company also relocated and expanded its Herbal Wellness Center in Jackson, Ohio, and sold its Kentucky medical cannabis processing license for $880,000.

Vext Science (OTCQX: VEXTF), a U.S.-based cannabis operator with operations in Arizona and Ohio, has scheduled the release of its Q1 2025 financial results for May 21, 2025, before market open. The company will host a conference call and webcast on the same day at 8:00 AM ET to discuss the results.

Interested participants can join via phone using the dial-in numbers +1-647-849-3159 or 1-833-752-3966 (Conference ID: 10199977). A replay will be available until June 4, 2025, using playback number 5885585. The webcast can be accessed at www.gowebcasting.com/14070, and a replay will be available on Vext's investor website after the call.

Vext Science (VEXTF) has announced the strategic sale of its Kentucky medical cannabis processing license for US$880,000 through its subsidiary Vapen Kentucky. The transaction aligns with the company's focused approach on its core markets in Arizona and Ohio.

Prior to the sale, on March 16, 2025, Vext acquired the remaining 50% membership interest in Vapen Kentucky from its joint venture partner using non-cash consideration. Following the transaction's closure, Vapen Kentucky will redirect its focus to hemp-related business opportunities.

The proceeds will be allocated towards:

• Repayment of existing credit facilities
• Development of Ohio retail footprint
• General corporate purposes

The transaction is expected to close in Q2 2025, subject to Kentucky state regulatory approval.

Vext Science (VEXTF) has completed the acquisition of two cannabis dispensaries from Big Perm's Dispensary Ohio for US$8.1 million, doubling its retail presence in Ohio. The acquisition adds locations in Athens and Jeffersonville to existing dispensaries in Jackson and Columbus.

The company is now fully vertically integrated in Ohio with:

• A Tier I cultivation facility (25,000 sq ft, expandable to 50,000 sq ft)
• A manufacturing facility
• Four operational medical and adult-use dispensaries

Vext has secured approval to develop three additional dual-use dispensaries and expects its Portsmouth location to commence operations in Q2/Q3 2025. The company is on track to reach Ohio's state license cap of eight dispensaries by early 2026, with cash flow projected to return to growth in Q4 2024.